Panagora Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History

Panagora Asset Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-45,517	Closed	-$341K	–	1576
2022 Q2	$341K	Sell	45,517 -3,514	-7%	-$24.8K	﹤0.01%	1278
2022 Q1	$446K	Buy	+49,031	New	+$378K	﹤0.01%	1250
2021 Q3	–	Sell	-69	Closed	-$1K	–	2668
2021 Q2	$1K	Buy	+69	New	+$1.18K	﹤0.01%	2741
2016 Q1	–	Sell	-1,689	Closed	-$41K	–	2358
2015 Q4	$41K	Buy	+1,689	New	+$39.4K	﹤0.01%	2030
2015 Q3	–	Sell	-1,477	Closed	-$26K	–	2463
2015 Q2	$26K	Sell	1,477 -6,648	-82%	-$122K	﹤0.01%	2265
2015 Q1	$255K	Buy	+8,125	New	+$236K	﹤0.01%	1574

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Panagora Asset Management's AERI Position: Q3 2022 in Review

Panagora Asset Management sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 45,517 shares — an estimated $341K sold.

Panagora Asset Management first reported a position in AERI in Q1 2015 and held it in 6 quarters. The position peaked at $446K in Q1 2022. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

Panagora Asset Management reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Panagora Asset Management sold 45,517 Aerie Pharmaceuticals shares in Q3 2022, an estimated $341K.
Panagora Asset Management first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Panagora Asset Management's Aerie Pharmaceuticals position peaked at $446K in Q1 2022.
156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Panagora Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.